VanEck JP Morgan EM Local Currency Bond ETF vs Tempus AI — how do they compare? VanEck JP Morgan EM Local Currency Bond ETF trades at $24.84 (market cap $4.93B), while Tempus AI trades at $70.04 (market cap $12.77B). The key difference: Tempus AI is far larger — about 2.6× VanEck JP Morgan EM Local Currency Bond ETF's market cap, and Tempus AI is trading nearer its 52-week high, VanEck JP Morgan EM Local Currency Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold VanEck JP Morgan EM Local Currency Bond ETF for 38 Days and Tempus AI for 22 Days on average.
| EMLC | TEM | |
|---|---|---|
Market Cap | $4.93B | $12.77B |
Volume | 2,301,346 | 8,980,490 |
Sector | Fixed Income | Broad Market / Factor |
52-Week High | $26.59 | $99.28 |
52-Week Low | $24.53 | $41.55 |
Typical Hold Time | 38 Days | 22 Days |
Enterprise Value | — | $13.40B |
Signals from Pluang's Aura AI — not financial advice
EMLC is trading at $24.77, down 0.24% on the day and hitting a new 52-week low. The technical picture remains bearish with moving averages signaling continued downward pressure. Recent news highlights challenges from a strengthening US dollar and Fed rate hikes impacting emerging market local currency bonds. The ETF faces headwinds as favorable currency tailwinds fade.
The outlook remains cautious with dollar strength and rising bond yields creating persistent pressure. Investment opportunity exists for long-term investors seeking emerging market bond exposure, but near-term risks from currency volatility and interest rate uncertainty warrant careful positioning. The fund's dividend payments provide some income cushion amid price volatility.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
EMLC invests in local currency-denominated government bonds from emerging market countries. It provides exposure to sovereign debt in nations like Brazil, Mexico, and South Africa, allowing investors to gain from high yields and potential local currency appreciation.
Read more on EMLC →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →